These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23213068)

  • 1. Circulating interferon-α2 levels are increased in the majority of patients with systemic lupus erythematosus and are associated with disease activity and multiple cytokine activation.
    Becker-Merok A; Østli-Eilersten G; Lester S; Nossent J
    Lupus; 2013 Feb; 22(2):155-63. PubMed ID: 23213068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum β2-microglobulin is associated with clinical and immunological markers of disease activity in systemic lupus erythematosus patients.
    Hermansen ML; Hummelshøj L; Lundsgaard D; Hornum L; Keller P; Fleckner J; Fox B; Poulsen LK; Jacobsen S
    Lupus; 2012 Sep; 21(10):1098-104. PubMed ID: 22577117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
    Kirou KA; Lee C; George S; Louca K; Peterson MG; Crow MK
    Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha- producing cells.
    Cederblad B; Blomberg S; Vallin H; Perers A; Alm GV; Rönnblom L
    J Autoimmun; 1998 Oct; 11(5):465-70. PubMed ID: 9802930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Th1/Th2 cytokine profile in childhood-onset systemic lupus erythematosus.
    Postal M; Peliçari KO; Sinicato NA; Marini R; Costallat LT; Appenzeller S
    Cytokine; 2013 Mar; 61(3):785-91. PubMed ID: 23332615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between peripheral blood dendritic cells and cytokines involved in the pathogenesis of systemic lupus erythematosus.
    Robak E; Smolewski P; Wozniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
    Eur Cytokine Netw; 2004; 15(3):222-30. PubMed ID: 15542447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential role of interferon-regulatory factor 7 among Taiwanese patients with systemic lupus erythematosus.
    Lin LH; Ling P; Liu MF
    J Rheumatol; 2011 Sep; 38(9):1914-9. PubMed ID: 21632682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type I interferon and T helper 17 cells co-exist and co-regulate disease pathogenesis in lupus patients.
    Biswas PS; Aggarwal R; Levesque MC; Maers K; Ramani K
    Int J Rheum Dis; 2015 Jul; 18(6):646-53. PubMed ID: 25960196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of autoantibodies against type I and type II interferons in a cohort of systemic lupus erythematosus patients in Slovakia.
    Slavikova M; Schmeisser H; Kontsekova E; Mateicka F; Borecky L; Kontsek P
    J Interferon Cytokine Res; 2003 Mar; 23(3):143-7. PubMed ID: 12716486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatigue in patients with systemic lupus erythematosus: lack of associations to serum cytokines, antiphospholipid antibodies, or other disease characteristics.
    Omdal R; Mellgren SI; Koldingsnes W; Jacobsen EA; Husby G
    J Rheumatol; 2002 Mar; 29(3):482-6. PubMed ID: 11908560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine imbalance in systemic lupus erythematosus: a study on northern Indian subjects.
    Arora V; Verma J; Marwah V; Kumar A; Anand D; Das N
    Lupus; 2012 May; 21(6):596-603. PubMed ID: 22300832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Feng X; Wu H; Grossman JM; Hanvivadhanakul P; FitzGerald JD; Park GS; Dong X; Chen W; Kim MH; Weng HH; Furst DE; Gorn A; McMahon M; Taylor M; Brahn E; Hahn BH; Tsao BP
    Arthritis Rheum; 2006 Sep; 54(9):2951-62. PubMed ID: 16947629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring interferon alpha and other cytokines in SLE.
    Olferiev M; Lliguicota M; Kirou KA; Crow MK
    Methods Mol Biol; 2014; 1134():131-50. PubMed ID: 24497359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of functional interleukin 10/tumor necrosis factor-alpha polymorphisms on interferon-alpha, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment.
    López P; Gómez J; Prado C; Gutiérrez C; Suárez A
    J Rheumatol; 2008 Aug; 35(8):1559-66. PubMed ID: 18597405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
    Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activity.
    Robak E; Sysa-Jedrzejewska A; Dziankowska B; Torzecka D; Chojnowski K; Robak T
    Arch Immunol Ther Exp (Warsz); 1998; 46(6):375-80. PubMed ID: 9883317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression of cytokines (TNF-α, IFN-γ), serum profiles of IL-17 and IL-23 in paediatric systemic lupus erythematosus.
    Rana A; Minz RW; Aggarwal R; Anand S; Pasricha N; Singh S
    Lupus; 2012 Sep; 21(10):1105-12. PubMed ID: 22759859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of interferon-α as a biomarker in central neuropsychiatric involvement in systemic lupus erythematosus.
    Fragoso-Loyo H; Atisha-Fregoso Y; Núñez-Alvarez CA; Llorente L; Sánchez-Guerrero J
    J Rheumatol; 2012 Mar; 39(3):504-9. PubMed ID: 22247358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE).
    Oke V; Brauner S; Larsson A; Gustafsson J; Zickert A; Gunnarsson I; Svenungsson E
    Arthritis Res Ther; 2017 Jun; 19(1):139. PubMed ID: 28619037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification.
    Munroe ME; Lu R; Zhao YD; Fife DA; Robertson JM; Guthridge JM; Niewold TB; Tsokos GC; Keith MP; Harley JB; James JA
    Ann Rheum Dis; 2016 Nov; 75(11):2014-2021. PubMed ID: 27088255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.